LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 7 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAVEN ROCK CAPITAL MANAGEMENT, LLC | 2,500,000 | $2,500,000 | 6.59% |
| LINDEN ADVISORS LP | 46,415,000 | $60,063,000 | 4.13% |
| Sage Capital Management, LLC | 2,000,000 | $2,588,000 | 3.77% |
| Man Investments (CH) AG | 4,000,000 | $5,185,000 | 2.55% |
| CAMDEN ASSET MANAGEMENT L P /CA | 37,150,000 | $48,318,000 | 1.65% |
| BASSO CAPITAL MANAGEMENT, L.P. | 7,220,000 | $9,323,000 | 1.54% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $31,664,000 | 0.75% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,000,000 | $10,350,000 | 0.30% |
| Wellesley Asset Management | 3,170 | $4,141,000 | 0.24% |
| CSS LLC/IL | 2,500,000 | $3,230,000 | 0.19% |